On April 14, 2022, the FDA released draft guidance that aims to diversify the population of participants in clinical trials.…
Read More
In November 2021, the National Institutes of Health (NIH) Office of Science Policy (OSP) published a Request for Information (RFI)…
Read MoreIn 2015, NIH solicited public input on an agency-wide strategic plan framework for the subsequent five years in response to…
Read MoreIn March, the Food and Drug Administration (FDA) issued a guidance, "Cancer Clinical Trial Eligibility Criteria: Minimum Age for Pediatric…
Read MoreThe Office for Civil Rights (OCR) within the Department of Health and Human Services (HHS) recently put out a "Request…
Read More